Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
28 sept. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023...